Ayşe KIRBAŞ, Korkut DAĞLAR, Hakan TİMUR, Zehra YILMAZ, Gulenay GENCOSMANOGLU, Nuri DANIŞMAN

Circulating ADAMTS-12 levels in early- and late-onset severe preeclampsia

Aim of this study is to determine whether maternal serum ADAMTS-12 levels differ among early-onset (

___

1. Harmon AC, Cornelius DC, Amaral LM, Faulkner JL, Cunningham MW Jr, Wallace K, LaMarca B. The role of inflammation in the pathology of preeclampsia. Clin Sci (Lond). 2016;130(6):409-19.

2. Kirbas O, Biberoglu EH, Kirbas A, Daglar HK, Kurmus O, Uygur D, Danisman N. P-wave duration changes and dispersion in preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2014;183:141-5.

3. Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008;52(5):873-80

4. Kirbas A, Ersoy AO, Daglar K, Dikici T, Biberoglu EH, Kirbas O, Danisman N. Prediction of preeclampsia by first trimester combined test and simple complete blood count parameters. J Clin Diagn Res. 2015;9(11):QC20-3.

5. Redman CW, Sargent IL, Staff AC. IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia? Placenta. 2014:35(Suppl):S20-5.

6. Palei AC, Granger JP, Tanus-Santos JE. Matrix metalloproteinases as drug targets in preeclampsia Curr Drug Targets. 2013;14(3):325-34.

7. Wei J, Richbourgh B, Jia T, Liu C. ADAMTS-12: a multifaced metalloproteinase in arthritis and inflammation. Mediators Inflamm. 2014;2014:649718.

8. Beristain AG, Zhu H, Leung PC. Regulated expression of ADAMTS- 12 in human trophoblastic cells: a role for ADAMTS-12 in epithelial cell invasion? PLoS One. 2011;6(4):e18473.

9. Eda Gökdemir İ, Özdeğirmenci Ö, Elmas B, Sarikaya E, Tokmak A, Kazanci FH, Gök S, Erkaya S, Demircan K. Evaluation of ADAMTS12, ADAMTS16, ADAMTS18 and IL-33 serum levels in pre-eclampsia. J Matern Fetal Neonatal Med. 2015;18:1-6.

10. Barfield WD. Committee on fetus and newborn. publications committee, society for maternal-fetal medicine, standard terminology for fetal, infant, and perinatal deaths. Pediatrics. 2011;128(1):177-81.

11. Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am J Obstet Gynecol 2011;205(3):191-8.

12. Palei AC, Granger JP, Tanus-Santos JE. Matrix metalloproteinases as drug targets in preeclampsia Curr Drug Targets. 2013;14(3):325-3